Rick Rouse, Investors Alley, Author at Daily Trade Alert

Caution: This Stock Remains Overvalued

As quarterly losses will continue into the foreseeable future, it still seems expensive at current levels.

High-yielding dividend stocks can be a red flag, but investors could continue to see a dividend yield between 20%–30% from this name.

It could be the next rare disease giant in the industry.

With shares trading near their recent 52-week low, it currently looks like a bargain.

Given its revenue growth, starting a small position at current levels might be a solid long-term investment.